Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells

Hepatobiliary and Pancreatic Diseases International

Volumn 10, Issue 5, 2011, Pages 502-508

  Wang, Qing Lan ^a,b,c   Wu, Quoc ^c   Tao, Yan Yan ^a   Liu, Cheng Hai ^a   El Nezami, Hani ^c,d  

^a SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine   (China)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CYP1A2; CYP3A4; Drug metabolizing enzymes; Glutathione S transferases; HepG2 cells; Salvianolic acid B

Indexed keywords

CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; DRUG METABOLIZING ENZYME; GLUTATHIONE TRANSFERASE; MESSENGER RNA; RIFAMPICIN; SALVIANOLIC ACID B;

ARTICLE; CELL PROLIFERATION; CHINESE HERB; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SALVIAE MILTIORRHIZAE; STAINING; WESTERN BLOTTING;

EID: 80053209620     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(11)60085-4     Document Type: Article

References (40)

1. Chan E, Tan M, Xin J, Sudarsanam S, Johnson DE. Interactions between traditional Chinese medicines and Western therapeutics. Curr Opin Drug Discov Devel 2010;13: 50-65.
2. Zuo XC, Zhang BK, Jia SJ, Liu SK, Zhou LY, Li J, et al. Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects. Eur J Clin Pharmacol 2010;66:503-509.
3. Fugh-Berman A. Herb-drug interactions. Lancet 2000;355: 134-138.
4. Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, et al. The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther 2003;74:525-535.
5. Tang J, Song X, Zhu M, Zhang J. Study on the pharmacokinetics drug-drug interaction potential of Glycyrrhiza uralensis, a traditional Chinese medicine, with lidocaine in rats. Phytother Res 2009;23:603-607.
6. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother 2000;34:1478-1482.
7. Muntané J. Regulation of drug metabolism and transporters. Curr Drug Metab 2009;10:932-945.
8. Nebert DW, Gonzalez FJ. P450 genes: structure, evolution, and regulation. Annu Rev Biochem 1987;56:945-993.
9. Boobis AR, Davies DS. Human cytochromes P-450. Xenobiotica 1984;14:151-185.
10. Gillette JR, Davis DC, Sasame HA. Cytochrome P-450 and its role in drug metabolism. Annu Rev Pharmacol 1972;12:57-84.
11. Coon MJ. Cytochrome P450: nature's most versatile biological catalyst. Annu Rev Pharmacol Toxicol 2005;45:1-25.
12. Dragovic S, Boerma JS, van Bergen L, Vermeulen NP, Commandeur JN. Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine. Chem Res Toxicol 2010;23:1467-1476.
13. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 2000; 294:88-95.
14. Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003;290: 1500-1504.
15. Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005;45:1345-1359.
16. Ueng YF, Kuo YH, Wang SY, Lin YL, Chen CF. Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice. Life Sci 2004;74:885-896.
17. Ueng YF, Kuo YH, Peng HC, Chen TL, Jan WC, Peter Guengerich F, et al. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2. Xenobiotica 2003;33:603-613.
18. Yan X, Zhou T, Tao Y, Wang Q, Liu P, Liu C. Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways. Exp Biol Med (Maywood) 2010;235:623-632.
19. Lin YL, Wu CH, Luo MH, Huang YJ, Wang CN, Shiao MS, et al. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J Ethnopharmacol 2006;105:215-222.
20. Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW. Anti inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets 2006;6: 279-304.
21. Chen YH, Lin SJ, Ku HH, Shiao MS, Lin FY, Chen JW, et al. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J Cell Biochem 2001;82:512-521.
22. Cosan DT, Bayram B, Soyocak A, Basaran A, Gunes HV, Degirmenci I, et al. Role of phenolic compounds in nitric oxide synthase activity in colon and breast adenocarcinoma. Cancer Biother Radiopharm 2010;25:577-580.
23. Lozano-Sánchez J, Segura-Carretero A, Menendez JA, Oliveras-Ferraros C, Cerretani L, Fernández-Gutiérrez A. Prediction of extra virgin olive oil varieties through their phenolic profile. Potential cytotoxic activity against human breast cancer cells. J Agric Food Chem 2010;58:9942-9955.
24. Kurata R, Adachi M, Yamakawa O, Yoshimoto M. Growth suppression of human cancer cells by polyphenolics from sweetpotato (Ipomoea batatas L.) leaves. J Agric Food Chem 2007;55:185-190.
25. Mertens-Talcott SU, Lee JH, Percival SS, Talcott ST. Induction of cell death in Caco-2 human colon carcinoma cells by ellagic acid rich fractions from muscadine grapes (Vitis rotundifolia). J Agric Food Chem 2006;54:5336-5343.
26. Burman WJ, Gallicano K, Peloquin C. Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials. Clin Pharmacokinet 2001;40:327-341.
27. Fung KP, Zeng LH, Wu J, Wong HN, Lee CM, Hon PM, et al. Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci 1993;52:PL239-PL244.
28. Au-Yeung KK, O K, Choy PC, Zhu DY, Siow YL. Magnesium tanshinoate B protects endothelial cells against oxidized lipoprotein-induced apoptosis. Can J Physiol Pharmacol 2007;85:1053-1062.
29. Guengerich FP. Metabolic activation of carcinogens. Pharmacol Ther 1992;54:17-61.
30. Guengerich FP. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 1988;48:2946-2954.
31. Yang CS, Chen L, Lee MJ, Landau JM. Effects of tea on carcinogenesis in animal models and humans. Adv Exp Med Biol 1996;401:51-61.
32. Harris CC. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 1991;51:5023s-5044s.
33. Bai XB, Liu CX. Overview of major CYP450 isoforms and Cocktail Approach. Asian Journal of Drug Metabolism and Pharmacokinetics 2005;5:257-264.
34. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-344.
35. Nose M, Tamura M, Ryu N, Mizukami H, Ogihara Y. Shosaiko-to and Saiko-keisi-to, the traditional Chinese and Japanese herbal medicines, altered hepatic drug-metabolizing enzymes in mice and rats when administered orally for a long time. J Pharm Pharmacol 2003;55:1419-1426.
36. Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol 2007;121:9-22.
37. Wang L, Xiong ZY, Wang G. Systematic assessment on randomized controlled trials for treatment of stable angina pectoris by compound salvia pellet. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24:500-504.
38. Zhou L, Chow M, Zuo Z. Improved quality control method for Danshen products--consideration of both hydrophilic and lipophilic active components. J Pharm Biomed Anal 2006;41:744-750.
39. Inaba T, Tyndale RE, Mahon WA. Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo. Br J Clin Pharmacol 1986;22:199-200.
40. Zhu M, Lin KF, Yeung RY, Li RC. Evaluation of the protective effects of Schisandra chinensis on Phase I drug metabolism using a CCl4 intoxication model. J Ethnopharmacol 1999;67: 61-68.